Diagnostic accuracy of pre-operative NT-proBNP level in predicting short-term outcomes in coronary surgery: A pilot study

Kardiologia Polska

Volumn 69, Issue 11, 2011, Pages 1121-1127

  Krzych, Łukasz J ^a   Szurlej, Dariusz ^a   Koołdziej, Tadeusz ^a   Machej, Leszek ^a   Weģlarzy, Andrzej ^a   Bałch, Andrzej ^a   Wilczynśki, Mirosałw ^a   Woś, Stanisałw ^a   Bochenek, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Coronary artery bypass grafting; Diagnostic accuracy; NT proBNP; Postoperative complications

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; INOTROPIC AGENT;

ANESTHESIA INDUCTION; ARTICLE; ARTIFICIAL VENTILATION; CORONARY ARTERY BYPASS GRAFT; COUNTERPULSATION; DELIRIUM; DIAGNOSTIC ACCURACY; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART OUTPUT; HEMODYNAMIC MONITORING; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; RESPIRATORY FAILURE; STROKE; SURGICAL DRAINAGE; SURGICAL PATIENT; SURGICAL RISK; THROMBOCYTE TRANSFUSION;

EID: 81555222793     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Clerico A, Fontana M, Zyw L, Passino C, Emdin M. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. Clin Chem, 2007; 53: 813-822. (Pubitemid 46744235)
2. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ, 2005; 330: 625.
3. Wita K, Kinasz L, Filipecki A et al. Risk factors of asymptomatic restenosis in patients with first anterior ST elevation myocardial infarction treated by primary percutaneous coronary intervention. Kardiol Pol, 2010; 68: 987-993.
4. Drewniak W, Snopek G, Zarukiewicz M, Borys M, Dabrowski M. Prognostic value of the N-terminal pro-B-type natriuretic peptide in the elderly with acute myocardial infarction. Kardiol Pol, 2008; 66: 750-755.
5. Vasan RS, Benjamin EJ, Larson MG et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA, 2002; 288: 1252-1259. (Pubitemid 35001328)
6. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart, 2005; 91: 606-612. (Pubitemid 40559349)
7. Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart, 2006; 92: 843-849. (Pubitemid 43799232)
8. Schachner T, Wiedemann D, Fetz H, Laufer G, Kocher A, Bonaros N. Influence of preoperative serum N-terminal pro-brain type natriuretic peptide on the postoperative outcome and survival rates of coronary artery bypass patients. Clinics (Sao Paulo), 2010; 65: 1239-1245.
9. Cuthbertson BH, Croal BL, Rae D et al. N-terminal pro-B-type natriuretic peptide levels and early outcome after cardiac surgery: a prospective cohort study. Br J Anaesth, 2009; 103: 647-653.
10. Rodseth RN, Padayachee L, Biccard BM. A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia, 2008; 63: 1226-1233.
11. Ganem F, Serrano CV, Fernandes JL et al. Preoperative B-type natriuretic peptide, and not the inflammation status, predicts an adverse outcome for patients undergoing heart surgery. Interact Cardiovasc Thorac Surg, doi:10.1510/icvts.2010.255257.
12. Nozohoor S, Nilsson J, Algotsson L, Sjögren J. Postoperative increase in B-type natriuretic peptide levels predicts adverse outcome after cardiac surgery. J Cardiothorac Vasc Anesth, doi:10.1053/j.2010.07.002.
13. Attaran S, Sherwood R, Desai J et al. Brain natriuretic peptide a predictive marker in cardiac surgery. Interact Cardiovasc Thorac Surg, 2009; 9: 662-666.
14. Wang Z, Liang D, Fu Q, Jia L, Men J, Wei M. Perioperative brain natriuretic peptide in off-pump coronary artery bypass. Acta Cardiol, 2010; 65: 297-301.
15. Hutfless R, Kazanegra R, Madani M et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol, 2004; 43: 1873-1879. (Pubitemid 38622529)
16. Gasparovic H, Burcar I, Kopjar T et al. NT-pro-BNP, but not C-reactive protein, is predictive of atrial fibrillation in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg, 2010; 37: 100-105.
17. Gibson PH, Croal BL, Cuthbertson BH et al. Use of preoperative natriuretic peptides and echocardiographic parameters in predicting new-onset atrial fibrillation after coronary artery bypass grafting: a prospective comparative study. Am Heart J, 2009; 158: 244-251.
18. Akazawa T, Nishihara H, Iwata H, Warabi K, Ohshima M, Inada E. Preoperative plasma brain natriuretic peptide level is an independent predictor of postoperative atrial fibrillation following off-pump coronary artery bypass surgery. J Anesth, 2008; 22: 347-353.
19. Tavakol M, Hassan KZ, Abdula RK et al. Utility of brain natriuretic peptide as a predictor of atrial fibrillation after cardiac operations. Ann Thorac Surg, 2009; 88: 802-807.
20. Kolditz M, Halank M, Schiemanck CS, Schmeisser A, Höffken G. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions. Eur Respir J, 2006; 28: 144-150. (Pubitemid 44914272)
21. Gegenhuber A, Mueller T, Dieplinger B, Lenz K, Poelz W, Haltmayer M. Plasma B-type natriuretic peptide in patients with pleural effusions: preliminary observations. Chest, 2005; 128: 1003-1009. (Pubitemid 41140539)
22. Carmona-Bernal C, Quintana-Gallego E, Villa-Gil M, Sánchez- Armengol A, Martínez-Martínez A, Capote F. Brain natriuretic peptide in patients with congestive heart failure and central sleep apnea. Chest, 2005; 127: 1667-1673. (Pubitemid 46218793)
23. Goei D, van Kuijk JP, Flu WJ et al. Usefulness of repeated N-terminal pro-B-type natriuretic Peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery. Am J Cardiol, 2011; 107: 609-614.
24. Chello M, Mastroroberto P, Perticone F et al. Plasma levels of atrial and brain natriuretic peptides as indicators of recovery of left ventricular systolic function after coronary artery bypass. Eur J Cardiothorac Surg, 2001; 20: 140-6.
25. Fox AA, Muehlschlegel JD, Body SC et al. Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting. Anesthesiology, 2010; 112: 842-851.
26. Kragelund C, Grønning B, Omland T et al. Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease? Am Heart J, 2006; 151: 712.e1-712.e7.
27. Ray P, Arthaud M, Lefort Y et al. Usefulness of B-type natriuretic peptide in elderly patients with acute dyspnea. Intensive Care Med, 2004; 30: 2230-2236. (Pubitemid 40174260)
28. Costello-Boerrigter LC, Boerrigter G, Redfield MM et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol, 2006; 47: 345-353. (Pubitemid 43063253)
29. Schnabel R, Lubos E, Rupprecht HJ et al. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study. J Am Coll Cardiol, 2006; 47: 552-558. (Pubitemid 43170843)
30. Krzych LJ, Liszka L. No improvement in studies reporting the diagnostic accuracy of B-type natriuretic peptide. Med Sci Monit, 2009; 15: SR5-SR14.